Anavex Life Sciences
AVXL
#7563
Rank
A$0.59 B
Marketcap
A$6.62
Share price
-1.12%
Change (1 day)
-43.78%
Change (1 year)

Anavex Life Sciences (AVXL) - Net assets

Net assets on the balance sheet as of June 2025 : A$0.13 Billion

According to Anavex Life Sciences 's latest financial reports the company has A$0.13 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Anavex Life Sciences - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$A$0.17 B-21.2%
2023-09-30$A$0.22 B-0.39%
2022-09-30$A$0.22 B6.22%
2021-09-30$A$0.20 B448.78%
2020-09-30$A$38 M26.49%
2019-09-30$A$30.04 M-2.77%
2018-09-30$A$30.89 M-0.05%
2017-09-30$A$30.91 M274.31%
2016-09-30$A$8.25 M-54.8%
2015-09-30$A$18.27 M8188.13%
2014-09-30$A$0.22 M-108.34%
2013-09-30$-A$2.65 Million-4.82%
2012-09-30$-A$2.78 Million136.77%
2011-09-30$-A$1.18 Million-61.8%
2010-09-30$-A$3.07 Million-30.9%
2009-09-30$-A$4.45 Million53.53%
2008-09-30$-A$2.9 Million459.52%
2007-09-30$-A$0.52 Million2387.11%
2006-09-30$-A$0.03 Million-39.31%
2005-09-30$-A$0.04 Million-195.92%
2004-09-30$A$0.03 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ligand Pharmaceuticals
LGND
A$1.43 B 944.63%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$0.59 Billion-526.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$0.95 B 594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$9.62 Million-107.02%๐Ÿ‡บ๐Ÿ‡ธ USA